Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barbara Bettegazzi

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Scientific Reports|September 7, 2017
eIF4B phosphorylation at Ser504 links synaptic activity with protein translation in physiology and pathologyBarbara Bettegazzi, Serena Bellani, Paolo Roncon, et al.
Frontiers in Cellular Neuroscience|April 4, 2022
Redox and Calcium Alterations of a Müller Cell Line Exposed to Diabetic Retinopathy-Like EnvironmentClarissa Rosato, Barbara Bettegazzi, Pia Intagliata, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|September 30, 2022
Low-dose 7,8-Dihydroxyflavone Administration After Status Epilepticus Prevents Epilepsy DevelopmentAnnunziata Guarino, Barbara Bettegazzi, Nimra Aziz, et al.
Disease Models & Mechanisms|May 26, 2018
Adding a temporal dimension to the study of Friedreich's ataxia: the effect of frataxin overexpression in a human cell modelTommaso Vannocci, Roberto Notario Manzano, Ombretta Beccalli, et al.
EMBO Reports|September 9, 2024
Gene therapy for epilepsy targeting neuropeptide Y and its Y2 receptor to dentate gyrus granule cellsStefano Cattaneo, Barbara Bettegazzi, Lucia Crippa, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 15, 2025
AAV-mediated gene therapy for focal epilepsy by expressing neuropeptide Y and Y2 receptor in rodent and non-human primate hippocampusBarbara Terzic, Esbjörn Melin, Pernilla Fagergren, et al.
Molecular Therapy. Methods & Clinical Development|April 19, 2021
Improvement of HSV-1 based amplicon vectors for a safe and long-lasting gene therapy in non-replicating cellsMarie Soukupová, Silvia Zucchini, Pascal Trempat, et al.
Molecular Neurobiology|April 26, 2025
An Insight into Neuronal Processing of Ghrelin: Effects of a Bioactive Ghrelin Derivative on Proteolytic Pathways and MitophagyDaniela Lufrano, Chunmei Gong, Valentina Cecarini, et al.
Gene Therapy|September 28, 2025
Genetic mutations in HSV-1 replication-defective vectors: Implications for their safety in gene therapy applicationsStefano Cattaneo, Barbara Bettegazzi, Selene Ingusci, et al.
European Journal of Pharmacology|August 11, 2024
In vitro pharmacological characterization of growth hormone secretagogue receptor ligands using the dynamic mass redistribution and calcium mobilization assaysChiara Sturaro, Chiara Ruzza, Federica Ferrari, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Scientific Reports|September 7, 2017
eIF4B phosphorylation at Ser504 links synaptic activity with protein translation in physiology and pathologyBarbara Bettegazzi, Serena Bellani, Paolo Roncon, et al.
Frontiers in Cellular Neuroscience|April 4, 2022
Redox and Calcium Alterations of a Müller Cell Line Exposed to Diabetic Retinopathy-Like EnvironmentClarissa Rosato, Barbara Bettegazzi, Pia Intagliata, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|September 30, 2022
Low-dose 7,8-Dihydroxyflavone Administration After Status Epilepticus Prevents Epilepsy DevelopmentAnnunziata Guarino, Barbara Bettegazzi, Nimra Aziz, et al.
Disease Models & Mechanisms|May 26, 2018
Adding a temporal dimension to the study of Friedreich's ataxia: the effect of frataxin overexpression in a human cell modelTommaso Vannocci, Roberto Notario Manzano, Ombretta Beccalli, et al.
EMBO Reports|September 9, 2024
Gene therapy for epilepsy targeting neuropeptide Y and its Y2 receptor to dentate gyrus granule cellsStefano Cattaneo, Barbara Bettegazzi, Lucia Crippa, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 15, 2025
AAV-mediated gene therapy for focal epilepsy by expressing neuropeptide Y and Y2 receptor in rodent and non-human primate hippocampusBarbara Terzic, Esbjörn Melin, Pernilla Fagergren, et al.
Molecular Therapy. Methods & Clinical Development|April 19, 2021
Improvement of HSV-1 based amplicon vectors for a safe and long-lasting gene therapy in non-replicating cellsMarie Soukupová, Silvia Zucchini, Pascal Trempat, et al.
Molecular Neurobiology|April 26, 2025
An Insight into Neuronal Processing of Ghrelin: Effects of a Bioactive Ghrelin Derivative on Proteolytic Pathways and MitophagyDaniela Lufrano, Chunmei Gong, Valentina Cecarini, et al.
Gene Therapy|September 28, 2025
Genetic mutations in HSV-1 replication-defective vectors: Implications for their safety in gene therapy applicationsStefano Cattaneo, Barbara Bettegazzi, Selene Ingusci, et al.
European Journal of Pharmacology|August 11, 2024
In vitro pharmacological characterization of growth hormone secretagogue receptor ligands using the dynamic mass redistribution and calcium mobilization assaysChiara Sturaro, Chiara Ruzza, Federica Ferrari, et al.
Pageof 3